Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Myriad Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.017 Good day, and thank you for standing by. Welcome to the Myriad Genetics fourth quarter 00:00:05.017 -- 00:00:07.359 and full year 2025 earnings 00:00:07.359 -- 00:00:11.965 call. At this time, all participants are in a listen-only mode. 00:00:11.965 -- 00:00:15.529 After the speaker's presentation, there will be a question and answer session. 00:00:15.529 -- 00:00:20.795 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:20.795 -- 00:00:25.200 You will then hear an automated message advising your hand is raised. 00:00:25.200 -- 00:00:28.752 To withdraw your question, please press star 11 again. 00:00:28.752 -- 00:00:31.877 please be advised that today's conference is being recorded. 00:00:31.877 -- 00:00:37.906 I would now like to hand the conference over to your first speaker today, Matt Scalo, 00:00:37.906 -- 00:00:40.730 Senior Vice President of Investor Relations. 00:00:40.730 -- 00:00:43.251 Please go ahead. 00:00:43.955 -- 00:00:49.183 Good afternoon, and welcome to Myriad Genetics' fourth quarter and full year 2025 earnings 00:00:49.183 -- 00:00:54.390 call. During the call, we will review the financial results we released today, and afterwards, 00:00:54.390 -- 00:01:00.410 we will host a Q&A session. Our earnings release was issued this afternoon on Form 8K 00:01:00.410 -- 00:01:04.113 and can be found on our website at investor.myriad.com. 00:01:04.737 -- 00:01:08.303 I'm Matt Scalo, Senior Vice President of Investor Relations. 00:01:08.303 -- 00:01:13.331 On the call with me today are Sam Raha, our President and Chief Executive Officer, Ben 00:01:13.331 -- 00:01:18.619 Wheeler, our Chief Financial Officer, and Mark Verratti, our Chief Operating Officer. 00:01:18.619 -- 00:01:23.4...